| Rank | Ticker | Exchange | Country | Price | Revenue | Analyst Rating | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | GMTL | Nasdaq | United Kingdom | $11.33 | $0.00 | Buy | 2026 |
#2 | BCHT | Nasdaq | United States | $1.43 | $0.00 | Strong Buy | 2026 |
#3 | MMED | Nasdaq | United States | $17.67 | $0.00 | Strong Buy | 2026 |
#4 | PAYP | Nasdaq | Japan | $16.02 | $0.00 | Buy | 2026 |
#5 | INFQ | Nasdaq | United States | $9.77 | $0.00 | Strong Buy | 2026 |
#6 | MDA | Nasdaq | Canada | $29.97 | $0.00 | Strong Buy | 2026 |
#7 | DMRC | Nasdaq | United States | $6.10 | $0.00 | Strong Buy | 2026 |
#8 | XOM | Nasdaq | United States | $154.78 | $0.00 | Buy | 2026 |
#9 | CRMT | Nasdaq | United States | $3.35 | $1,281,502,000.00 | Buy | 2026 |
The FinQuota filters have identified what they believe to be the "Best New Stocks & Recent IPOs (July 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.